1. Home
  2. Analysis
  3. Integrilin
  4. Reglan

Integrilin and Reglan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Integrilin (eptifibatide) and Reglan (metoclopramide hydrochloride). Common drug interactions include atrial fibrillation among females and cardiogenic shock among males.

The phase IV clinical study analyzes what interactions people have when they take Integrilin and Reglan. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Integrilin?

Integrilin has active ingredients of eptifibatide. eHealthMe is studying from 3,037 Integrilin users. Check the latest studies of Integrilin.

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 29,455 Reglan users. Check the latest studies of Reglan.

On Jul, 25, 2026

13 people who take Integrilin and Reglan together, and have interactions are studied.

Integrilin and Reglan drug interactions.

What are the common drug interactions of Integrilin and Reglan, by gender? *:

female:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Blood pressure decreased
  3. Blood urea increased
  4. Bradycardia (abnormally slow heart action)
  5. Cardiac arrest
  6. Confusional state
  7. Constipation
  8. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  9. Decreased appetite
  10. Deformity (disfigurement)

male:

  1. Cardiogenic shock (inadequate circulation of blood)
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Vomiting
  4. Abdominal pain upper
  5. Anxiety
  6. Death
  7. Depression
  8. Haemoglobin decreased
  9. Haemorrhage intracranial (bleeding within the skull)
  10. Injury

What are the common drug interactions of Integrilin and Reglan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Blood creatinine increased
  2. Renal failure (kidney dysfunction)

60+:

  1. Cardiac arrest
  2. Confusional state
  3. Anxiety
  4. Chest pain
  5. Injury
  6. Pain
  7. Abdominal pain upper
  8. Acute myocardial infarction (acute heart attack)
  9. Angina pectoris (chest pain due to ischemia of the heart muscle)
  10. Apnoea (suspension of external breathing)

What are the existing conditions these people have? *

  1. High Blood Pressure: 1 person, 7.69%
  2. Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Integrilin and Reglan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Integrilin and Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Integrilin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Integrilin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Reglan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eptifibatide and metoclopramide hydrochloride (the active ingredients of Integrilin and Reglan, respectively), and Integrilin and Reglan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.